BMI正常化与1型糖尿病进展风险降低相关,主要见于青少年
在TrialNet Pathway to Prevention研究的833例自身抗体阳性且基线超重或肥胖参与者中,中位随访4.1年,26.8%的参与者BMI恢复正常。BMI正常化与进展至3期1型糖尿病风险降低相关(HR 0.516,P<0.001),该关联主要见于青少年而非成人。
要点
- 自身抗体阳性超重/肥胖者中,BMI正常化与3期T1D风险降低约48%相关。
- 该保护性关联主要见于青少年,成人中未观察到显著关联。
- BMI正常化还与1期向2期、2期向3期进展风险降低相关。
核心结论
- 在自身抗体阳性超重或肥胖个体中,BMI正常化与临床1型糖尿病风险降低48.4%相关,主要见于青少年。
研究设计与样本
- TrialNet Pathway to Prevention研究中的833例自身抗体阳性且基线超重或肥胖参与者,采用Cox比例风险模型评估3期T1D累积发病率。
主要发现
- 中位随访4.1年期间,26.8%的参与者BMI恢复正常,与3期T1D进展风险降低相关(HR 0.516,P<0.001)。
- 该关联主要见于青少年(n=421,HR 0.497,P=0.001),包括<12岁男孩(n=140,P<0.001)和≥12岁女孩(n=73,P=0.043),成人中不显著(n=412,P=0.130)。
- BMI正常化与1期向2期进展风险降低(P=0.010)及2期向3期进展风险降低(P=0.003)相关,但与0期向1期进展的关联不明确(P=0.051)。
- 探索性模型中,调整胰岛素敏感性/抵抗指数或口服处置指数削弱了BMI正常化与进展风险的关联,而调整胰岛素分泌、血糖校正C肽或进展风险指数则一般增强该关联。
临床怎么用
- 对于自身抗体阳性且超重或肥胖的青少年,促进BMI正常化可能有助于降低进展至3期1型糖尿病的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Elevated BMI is associated with increased risk of progression to stage 3 type 1 diabetes (T1D). We tested whether normalization of BMI is associated with lower stage 3 risk among autoantibody-positive individuals with overweight or obesity. RESEARCH DESIGN AND METHODS: We studied 833 autoantibody-positive participants in the TrialNet Pathway to Prevention study with overweight or obesity at baseline. Cumulative incidence of stage 3 T1D was evaluated using Cox proportional hazards models. Reported P values were adjusted for baseline age, BMI z score, and T1D stage, unless otherwise noted. RESULTS: During follow-up, BMI normalized in 26.8% of participants and was associated with a lower risk of progression to stage 3 T1D (hazard ratio 0.516, P < 0.001) over a median follow-up time of 4.1 years. This association was primarily observed in youth (n = 421, hazard ratio 0.497, P = 0.001), including boys <12 years old (n = 140, P < 0.001) and girls ≥12 years old (n = 73, P = 0.043), but not in adults (n = 412, P = 0.130). BMI normalization was also associated with a lower risk of transition from stage 1 to stage 2 and from stage 2 to stage 3, but not clearly from stage 0 to stage 1 (P = 0.010, P = 0.003, and P = 0.051, respectively, adjusted for baseline age and BMI z score). In exploratory models, adjustment for insulin sensitivity/resistance indices or oral disposition index weakened the association between BMI normalization and lower progression risk, whereas adjustment for insulin secretion, glycemia-adjusted C-peptide, or progression-risk indices generally strengthened it. CONCLUSIONS: Among autoantibody-positive individuals with overweight or obesity, BMI normalization was associated with a 48.4% lower risk of clinical T1D, primarily in youth.
引用
- Redondo MJ, Cuthbertson D, Gupta R, et al. BMI Normalization Is Associated With Lower Risk of Progression to Type 1 Diabetes, Primarily in Youth. Diabetes Care. 2026. PMID: 42461847. doi:10.2337/dc26-0833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。